NCT04089696View on ClinicalTrials.gov

"Validation of the ExSpiron© in Patients With ALS"

NANot yet recruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Amyotrophic Lateral SclerosisNeuromuscular Diseases

Interventions

DEVICE

ExSprion

The primary objective is the validation of the ExSpiron© non-invasive monitor in patients diagnosed with ALS.

All Listed Sponsors

lead

University Medical Center Groningen

OTHER

NCT04089696 - "Validation of the ExSpiron© in Patients With ALS" | Biotech Hunter | Biotech Hunter